Clopidogrel Versus Aspirin for the Treatment of Acute Coronary Syndrome After a 12-Month Dual Antiplatelet Therapy: A Cost-effectiveness Analysis From China Payer's Perspective-Reference-Cited by-同舟云学术

Clopidogrel Versus Aspirin for the Treatment of Acute Coronary Syndrome After a 12-Month Dual Antiplatelet Therapy: A Cost-effectiveness Analysis From China Payer's Perspective

Published:2018-12 Issue:12 Volume:40 Page:2125-2137
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Zhang Lei,Lin Ziyi,Yin Hongjun,Liu Jing,Xuan Jianwei

Funder

Sanofi, China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. The China Acute Myocardial Infarction (CAMI) registry: a national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China;Xu;Am Heart J,2016

2. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular Angiography and interventions;Levine;Circulation,2011

3. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

4. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American heart association task force on practice guidelines;Amsterdam;Circulation,2014

5. Chinese guideline for percutaneous coronary intervention (2016) [article in Chinese];Chinese Society of Cardiology;Chin J Cardio,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of aspirin combination/clopidogrel combination on high-sensitivity C-reactive protein and P-selectin levels in patients with acute coronary syndrome;Tropical Journal of Pharmaceutical Research;2024-05-10

2. Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China;BMC Public Health;2023-08-11

3. Cost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China;Journal of Medical Economics;2020-02-24

4. Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis;Advances in Therapy;2019-06-01

5. Clopidogrel vs aspirin in acute coronary syndrome in China;PharmacoEconomics & Outcomes News;2018-12